Bayer AG Financials

Market Capitalization €20.43 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	28.37
Forward PE	2.97
Price to Sales TTM	€0.44
Price to Book MRQ	€0.67
Enterprise to Revenue	1.22
Enterprise to EBITDA	5.62

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-1.88%
Operating Margin	-38.34%
Return on Assets TTM	5.11%
Return on Equity TTM	-2.73%

Income Statement

Revenue TTM	€46,739,001,344
Revenue per Share TTM	€47.58
Quarterly Revenue Growth	-3.60%
Gross Profit TTM	€26,709,000,192
EBITDA	€9,363,000,000
Net Income to Common TTM	€-880,000,000
Diluted EPS TTM	€-0.89
Quarterly Earnings Growth YoY	-3.62%

Balance Sheet

Total Cash MRQ	€4,618,999,808
Total Cash per Share MRQ	€4.70
Total Debt MRQ	€
Total Debt to Equity MRQ	134.10
Current Ratio MRQ	1.32
Book Value per Share MRQ	€31.12

Cash Flow

Operating Cash Flow TTM	€7,977,999,872
Levered Free Cash Flow TTM	€3,329,999,872

BAYN Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	982,424,000
Float Shares	981,816,870
Avg 10 Volume	18,406
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.00%
% Held by Institutions	47.29%

Stock Price Summary

Beta
Fifty Two Week Low	€18.50
Fifty Two Week High	€31.80
Fifty Two Week Change	-47.30%
Day 50 MA	€19.98
Day 200 MA	€25.49

Dividends and Splits

Forward Annual Dividend Rate	€0.44
Forward Annual Dividend Yield	2.10%
Trailing Annual Dividend Rate	€0.11
Trailing Annual Dividend Yield	0.53%
Payout Ratio	163.27%
Dividend Date
Ex Dividend Date	2024-04-29
Last Split Factor
Last Split Date